GILMAN STEVEN C 4
4 · Vericel Corp · Filed Oct 4, 2024
Insider Transaction Report
Form 4
Vericel CorpVCEL
GILMAN STEVEN C
Director
Transactions
- Exercise/Conversion
Common Stock
2024-10-02$13.05/sh+5,833$76,121→ 16,833 total - Sale
Common Stock
2024-10-02$40.35/sh−5,833$235,362→ 11,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-02+5,833→ 5,833 totalExercise: $13.05Exp: 2028-05-02→ Common Stock (5,833 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024.
- [F2]These options, representing the right to purchase 17,500 shares, became exercisable in equal monthly installments over a period of one year, beginning on May 2, 2018, contingent upon continued service to the Company.